Early research (Phase 1)Looking for participantsNCT06756451
What this trial is testing
This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Who this might be right for
Hematologic Malignancies
Nanjing RegeneCore Biotech Co., Ltd. 71